Prostate Cancer

Top Story

Fewer newly diagnosed patients with cancer lack insurance after ACA

Fewer newly diagnosed patients with cancer lack insurance after ACA
October 19, 2017

Uninsurance rates among patients newly diagnosed with cancer dropped one-third during the Affordable Care Act’s first year of implementation, according to study results.

Since implementation of the ACA in 2014, the number of uninsured individuals has reached a historical low.

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress

October 17, 2017
Oncology leaders who participated in an American Association for Cancer Research webinar this afternoon highlighted several advances in cancer research and emphasized…

NIH collaboration aims to identify, validate immunotherapy biomarkers

October 13, 2017
NIH launched the Partnership for Accelerating Cancer Therapies, a 5-year public-private research collaboration. The $215 million effort is part of the national cancer…
In the Journals PlusPerspective

Genetic variant predicts clinical response to prostate cancer therapy

October 12, 2017
The presence of HSD3B1 variant predicted clinical outcomes to certain therapies among men treated for localized and metastatic castration-resistant prostate cancers…
More Headlines »
CME

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
Video
Meeting News

VIDEO: Visiting expert program helps community providers learn about immuno-oncology

June 12, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

What's Hot in Melanoma? Highlights from the HemOnc Today Melanoma and Cutaneous Malignancies 2017 Meeting

This activity is supported by an educational grant from Merck & Co, Inc.

The development and integration of targeted therapies, as well as immunotherapies, into clinical strategies for the…
More »
Advertisement
Advertisement